Cargando…
Intake of copper has no effect on cognition in patients with mild Alzheimer’s disease: a pilot phase 2 clinical trial
Disturbed copper (Cu) homeostasis may be associated with the pathological processes in Alzheimer’s disease (AD). In the present report, we evaluated the efficacy of oral Cu supplementation in the treatment of AD in a prospective, randomized, double-blind, placebo-controlled phase 2 clinical trial in...
Autores principales: | Kessler, Holger, Bayer, Thomas A., Bach, Daniela, Schneider-Axmann, Thomas, Supprian, Tillmann, Herrmann, Wolfgang, Haber, Manfred, Multhaup, Gerd, Falkai, Peter, Pajonk, Frank-Gerald |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2516533/ https://www.ncbi.nlm.nih.gov/pubmed/18587525 http://dx.doi.org/10.1007/s00702-008-0080-1 |
Ejemplares similares
-
Increased EEG gamma band activity in Alzheimer’s disease and mild cognitive impairment
por: van Deursen, J. A., et al.
Publicado: (2008) -
Magnetic resonance imaging for monitoring therapeutic response in a transgenic mouse model of Alzheimer’s disease using voxel-based analysis of amyloid plaques
por: Kim, Jae-Hun, et al.
Publicado: (2014) -
Automatic Detection of Cognitive Impairments through Acoustic Analysis of Speech
por: Nagumo, Ryosuke, et al.
Publicado: (2020) -
Disturbed Copper Bioavailability in Alzheimer's Disease
por: Kaden, Daniela, et al.
Publicado: (2011) -
Facilitators and barriers to a dietitian‐implemented blended care weight‐loss intervention (SMARTsize): a qualitative study
por: Heideman, W. H., et al.
Publicado: (2019)